We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Vascular Reconstruction Device and Delivery System

By HospiMedica staff writers
Posted on 19 Jan 2007
A vascular reconstruction device (VRD) and delivery system assists surgeons in the treatment of intracranial aneurysms with neuro-stent technology.

The Cordis Enterprise VRD is pre-loaded onto a delivery system composed of an introducer and delivery wire, creating a simple system configuration. More...
The VRD has three radiopaque zones to facilitate placement and visibility during coiling procedures, enabling physicians to recapture the stent if necessary. A flexible closed cell design provides conformability and true vessel reconstruction at the neck of the aneurysm and an advanced scaffold for coil support, holding the coils in place inside the aneurysm. The Enterprise VRD is a product of Cordis Neurovascular (Waterloo, Belgium), and has been approved in Europe to assist in coiling procedures.

Dr. Martin Bendzus of Cordis commented, "Patients that could hardly be treated before will be treated much more safely via an endovascular procedure with Cordis Enterprise.”

An intracranial aneurysm is a weak spot in the wall of a blood vessel in the brain that balloons out, forming a thin walled bubble or sac. Hemorrhagic stroke occurs when a cerebral aneurysm bursts and bleeds into brain tissue. Coiling procedures offer an endovascular neurointervention in which coils (implantable medical devices made of long strands of very thin, coiled wire) are used to fill aneurysms to facilitate clot formation and occlude blood flow to reduce the risk of aneurysm rupture.



Related Links:
Cordis Neurovascular

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mobile X-Ray System
K4W
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.